Near observation and Recurrent titration are warranted right up until ache management is secure on the new opioid. Observe sufferers for signs and indications of opioid withdrawal and for signs of oversedation/toxicity just after converting sufferers to OXYCONTIN.Don't abruptly discontinue OXYCONTIN in individuals who could possibly be bodily depen